Baseclick, a spin-off from BASF SE and Ludwig-Maximilians-Universität Munich, has raised an additional €1.2m (£1.1m) from private investors and BASF Venture Capital in a second round of financing.
Baseclick’s technology allows users to label multiple dye molecules on DNA strands in a sequence-specific manner.
The attachment of multiple dyes enables several or highly complex analyses to be carried out in a single operation.
Applications include analyses for pathogens such as HIV, hepatitis, or even tumour cells. The technique can also be used to detect mutations in human, animal and plant genomes.
‘We will use the capital raised to expand our existing activities in DNA technologies,’ said Dr Thomas Frischmuth, general manager of Baseclick. In addition, the company will build up a business for diagnostic technologies.